UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Past, Present, and Future of Non-Viral CAR T Cells

Frontiers in immunology, 2022-06, Vol.13, p.867013-867013

2022

Volltextzugriff (PDF)

Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities

The Journal of clinical investigation, 2020-11, Vol.130 (11), p.6021-6033

2020

Volltextzugriff (PDF)

Genome Editing in Engineered T Cells for Cancer Immunotherapy

Human gene therapy, 2023-09, Vol.34 (17-18), p.853-869

2023

Volltextzugriff (PDF)

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

Nature medicine, 2013-06, Vol.19 (6), p.739-746

2013

Volltextzugriff (PDF)

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells

European journal of immunology, 2011-06, Vol.41 (6), p.1652-1662

2011

Volltextzugriff (PDF)

Targeting of acute myeloid leukaemia by cytokine‐induced killer cells redirected with a novel CD123‐specific chimeric antigen receptor

British journal of haematology, 2013-05, Vol.161 (3), p.389-401

2013

Volltextzugriff (PDF)

Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells

Leukemia, 2020-10, Vol.34 (10), p.2688-2703

2020

Volltextzugriff (PDF)

Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors

Oncoimmunology, 2024-12, Vol.13 (1), p.2412371

2024

Volltextzugriff (PDF)

Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia

Journal of autoimmunity, 2017-12, Vol.85, p.141-152

2017

Volltextzugriff (PDF)

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Human gene therapy, 2018-05, Vol.29 (5), p.602-613

2018

Volltextzugriff (PDF)

Interphase Design of Cellulose Nanocrystals/Poly(hydroxybutyrate-ran-valerate) Bionanocomposites for Mechanical and Thermal Properties Tuning

Biomacromolecules, 2020-05, Vol.21 (5), p.1892-1901

2020

Volltextzugriff (PDF)

Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells

Leukemia, 2024-09

2024

Volltextzugriff (PDF)

Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?

Cells (Basel, Switzerland), 2020-05, Vol.9 (6), p.1337

2020

Volltextzugriff (PDF)

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

Molecular therapy, 2017-08, Vol.25 (8), p.1933-1945

2017

Volltextzugriff (PDF)

Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells

Molecular therapy, 2012-09, Vol.20 (9), p.1778-1790

2012

Volltextzugriff (PDF)

Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B‐cell acute lymphoblastic leukaemia

British journal of haematology, 2018-09, Vol.182 (6), p.939-943

2018

Volltextzugriff (PDF)

TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B‐cell precursor acute lymphoblastic leukaemia

British journal of haematology, 2018-08, Vol.182 (3), p.434-436

2018

Volltextzugriff (PDF)

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

Molecular therapy. Oncolytics, 2023-09, Vol.30, p.56-71

2023

Volltextzugriff (PDF)

Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform

Oncotarget, 2016-08, Vol.7 (32), p.51581-51597

2016

Volltextzugriff (PDF)

P1361: SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR‐CIK CELLS TOWARD A MULTI‐TARGETING STRATEGY IN B‐ALL

HemaSphere, 2023-08, Vol.7 (S3), p.e1590828-n/a

2023

Volltextzugriff (PDF)

P430: COMBINATORIAL ADAPTOR‐MEDIATED TARGETING OF ACUTE MYELOID LEUKEMIA WITH CAR T‐CELLS

HemaSphere, 2023-08, Vol.7 (S3), p.e8788701-n/a

2023

Volltextzugriff (PDF)

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

Molecular therapy. Oncolytics, 2023-09, Vol.30, p.150-150

2023

Volltextzugriff (PDF)

Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives

Frontiers in oncology, 2013-01, Vol.3, p.106

2013

Volltextzugriff (PDF)

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathway

Blood, 2010-08, Vol.116 (6), p.935-944

2010

Volltextzugriff (PDF)

Role of Microenvironment in Influencing the Activity of CD19 CAR T Cells in B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)

Blood, 2023-11, Vol.142 (Supplement 1), p.3475-3475

2023

Volltextzugriff (PDF)

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(398)
Mit Volltextzugriff
(368)

Publikationsform

Sprache

Englisch
(442)
Italienisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Past, Present, and Future of Non-Viral CAR T Cells

Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities

Genome Editing in Engineered T Cells for Cancer Immunotherapy

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells

Targeting of acute myeloid leukaemia by cytokine‐induced killer cells redirected with a novel CD123‐specific chimeric antigen receptor

Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells

Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors

Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia

Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia

Interphase Design of Cellulose Nanocrystals/Poly(hydroxybutyrate-ran-valerate) Bionanocomposites for Mechanical and Thermal Properties Tuning

Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells

Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells

Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B‐cell acute lymphoblastic leukaemia

TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B‐cell precursor acute lymphoblastic leukaemia

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform

P1361: SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR‐CIK CELLS TOWARD A MULTI‐TARGETING STRATEGY IN B‐ALL

P430: COMBINATORIAL ADAPTOR‐MEDIATED TARGETING OF ACUTE MYELOID LEUKEMIA WITH CAR T‐CELLS

Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells

Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathway

Role of Microenvironment in Influencing the Activity of CD19 CAR T Cells in B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)

Suchergebnisse filtern